Home NDC 0074-2340 Norvir
Product NDC 0074-2340
11-digit product format 000742340
Labeler code 0074
Product ID 0074-2340_389fa9db-7528-4d2a-9518-8909d396177b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ritonavir
Dosage form TABLET, FILM COATED
Route ORAL
Labeler AbbVie Inc.
Application NDA022417
Marketing category NDA
Marketing start 2022-08-16
Substance RITONAVIR
Active strength 100 mg/1
Pharmacologic classes Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022417-001 NORVIR RITONAVIR 100MG TABLET / ORAL AB RLD 2010-02-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022417-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD 2010-02-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD 2010-02-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022417-001 NORVIR 100MG TABLET / ORAL AB RLD, RS 2010-02-10 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Observed Orange Book patent history# Patent history page 1 of 2 · 48 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N022417-001 7148359 2019-07-19 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 7148359*PED 2020-01-19 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 7364752 2020-11-10 U-688 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 7364752*PED 2021-05-10 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 8268349 2024-08-25 Drug product 2012-09-26 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 8399015 2024-08-25 Drug product 2013-04-08 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 8691878 2024-08-25 U-688 2014-06-10 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 8268349*PED 2025-02-25 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 8399015*PED 2025-02-25 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 8691878*PED 2025-02-25 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 8470347 2026-09-17 Drug product 2013-07-12 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022417-001 8470347*PED 2027-03-17 Pediatric extension 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N022417-001 7148359 2019-07-19 Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 7148359*PED 2020-01-19 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 7364752 2020-11-10 U-688 Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 7364752*PED 2021-05-10 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 8268349 2024-08-25 Drug product 2012-09-26 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 8399015 2024-08-25 Drug product 2013-04-08 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 8691878 2024-08-25 U-688 2014-06-10 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 8268349*PED 2025-02-25 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 8399015*PED 2025-02-25 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 8691878*PED 2025-02-25 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 8470347 2026-09-17 Drug product 2013-07-12 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022417-001 8470347*PED 2027-03-17 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022417-001 7148359 2019-07-19 Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 7148359*PED 2020-01-19 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 7364752 2020-11-10 U-688 Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 7364752*PED 2021-05-10 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 8268349 2024-08-25 Drug product 2012-09-26 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 8399015 2024-08-25 Drug product 2013-04-08 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 8691878 2024-08-25 U-688 2014-06-10 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 8268349*PED 2025-02-25 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 8399015*PED 2025-02-25 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 8691878*PED 2025-02-25 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 8470347 2026-09-17 Drug product 2013-07-12 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022417-001 8470347*PED 2027-03-17 Pediatric extension b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022417-001 7148359 2019-07-19 Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N022417-001 7148359*PED 2020-01-19 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N022417-001 7364752 2020-11-10 U-688 Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N022417-001 7364752*PED 2021-05-10 Pediatric extension ea99ee380514…
Additional Listing Data#
Finished product Yes
Brand name base Norvir
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RITONAVIR 100 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination O3J8G9O825 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 152971 Internal RxNorm lookup 199249 Internal RxNorm lookup 900575 Internal RxNorm lookup 900577 Internal RxNorm lookup 1926066 Internal RxNorm lookup 1926069 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0074-2340-30 Norvir 30 in 1 BOTTLE TABLET, FILM COATED 30 1651
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RITONAVIR ACTIVE INGREDIENT O3J8G9O825 NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 RITONAVIR ACTIVE MOIETY O3J8G9O825 NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 ALCOHOL INACTIVE INGREDIENT 3K9958V90M NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 ANHYDROUS CITRIC ACID INACTIVE INGREDIENT XF417D3PSL NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 ANHYDROUS DIBASIC CALCIUM PHOSPHATE INACTIVE INGREDIENT L11K75P92J NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 CARAMEL INACTIVE INGREDIENT T9D99G2B1R NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 COPOVIDONE K25-31 INACTIVE INGREDIENT D9C330MD8B NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 PEPPERMINT OIL INACTIVE INGREDIENT AV092KU4JH NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 POLYETHYLENE GLYCOL 3350 INACTIVE INGREDIENT G2M7P15E5P NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 POLYOXYL 35 CASTOR OIL INACTIVE INGREDIENT 6D4M1DAL6O NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 SACCHARIN SODIUM INACTIVE INGREDIENT SB8ZUX40TY NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 SODIUM STEARYL FUMARATE INACTIVE INGREDIENT 7CV7WJK4UI NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 SORBITAN MONOLAURATE INACTIVE INGREDIENT 6W9PS8B71J NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 TALC INACTIVE INGREDIENT 7SEV7J4R1U NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509 WATER INACTIVE INGREDIENT 059QF0KO0R NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] 1509
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0074-2340 NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION NORVIR (RITONAVIR) POWDER [ABBVIE INC.] 1649 Current NDC, Legacy NDC, 1 package rows 20250223_2849298e-de6e-47bb-8194-56e075b33fc3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0074-2340-30 00074234030 30 TABLET, FILM COATED in 1 BOTTLE (0074-2340-30) 2022-08-16 0000-00-00 No No Current